NZeno was founded by Paul Tan, Olga Garkavenko, Bob Elliott.

Who are NZeno's investors?

NZeno's investors include Cure Kids Ventures, NZ Growth Capital Partners, Pacific Channel.

Where is NZeno headquartered?

NZeno is headquartered in New Zealand, NZ.

NZeno

New Zealand, NZ · 3 known investors

Find your way into NZeno

11 people in our graph share verified history with the NZeno team — schools, employers, funds. One of them is your warm intro.

Philip YEOunlockedknows Paul Tan · together at National University of Singapore (overlapped)

×3knows the team · via NZBio

×5knows the team · via University of Auckland

×2knows the team · via Auckland District Health Board

NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.

Biotech Healthtech Medical Devices

Founders & leadership

Paul Tan inFounder Director & Chief Medical OfficerPaul Tan is Founder Director and Chief Medical Officer of NZeno, a biotechnology company developing porcine cell-based therapeutics and xenotransplantation technologies. He has over 20 years of experience in biotechnology and therapeutic development, including prior involvement in clinical human xenotransplantation work.

Olga Garkavenko inFounder Director & Chief Scientific OfficerOlga Garkavenko is Founder Director and Chief Scientific Officer of NZeno, a biotechnology company developing porcine cell-based therapeutics and xenotransplantation technologies. She holds three patents in cell biology and has expertise in cell and regenerative medicine research, regulatory compliance, and scientific communication across multiple languages.

Bob ElliottFounder & Director (Retired 2020)

Peter LaiChief Executive Officer

Board

Howard Moore inChairman of the Board of DirectorsDirector at Cure Kids Ventures

Investors · 3

Cure Kids VenturesAuckland

NZ Growth Capital PartnersAuckland

Pacific ChannelAuckland

Frequently asked questions

What does NZeno do?: NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.
Who founded NZeno?: NZeno was founded by Paul Tan, Olga Garkavenko, Bob Elliott.
Who are NZeno's investors?: NZeno's investors include Cure Kids Ventures, NZ Growth Capital Partners, Pacific Channel.
Where is NZeno headquartered?: NZeno is headquartered in New Zealand, NZ.